gnail: Here is the calculation (assumption) Total revenue : RM59mil Total revenue (export) : 59 x 25 percent (assuming increase in export from 21 to 25) as per x 10percent (currency gain) Total currency gain= 1.4mil (as per quarter report)
1) Record revenue and profits in last 2 quarters(net profit +70% in last 2 quarters)
2) Significant improvement in profit margin
3) Foreign currency gain when MYR weakens (2014Q4 gain 1.9mil; 2015Q1 gain 1.4mil)
4) Stable business, topline grows every year,defensive and profitable company. Fundamentally strong.
5) Growth stock: It won contract from Singaporegovernment last year. Its new manufacturing plant in Indonesia could go forproduction end of this year. New products registration every year. Growing export market. Current export market contributes 20% for topline.
6) Bright industry outlook. Pharma sector alsooutperforms broad market this year.
7) Reasonable valuation at PE = 13. There is chancefor higher valuation if the growth momentum is sustainable. YSP has the lowestPE compare with its peers.
8) As of 30 Apr 2015, Main shareholder hold 53.45%shares, Lembaga 10%. Top 30 shareholders already hold 78.72%. This suggest thatthe stock is tightly held with limited supply in market. In fact, the stock hasbeen very thinly traded in past, until breakout with volume on 15/5/2015, afterquarter result announcement on 14/5/2015. (Note: Lembaga has been actively paringdown its holding since May15 to 5%++ only now)
Eelyn Soon hahahaha.... this is the one of the cheapest pharma counter with good dividend yield that has yet to move.. and pharma will never die no matter what.. as everyone gets sick all the time.. and doctors will still hv to prescribe medications to patients... js compare it with ahealth, pharmaniaga, ccmdbio, etcetc... any of them at this price level still? 16/04/2015 19:19
Eelyn Soon Don worry js hold onto it n buy more when retrace. 18/05/2015 17:24
Eelyn Soon js enjoy the ride.. 6.5 cts dividend is on the way.. more to come... with big boys holding such a huge chunks of shares.. 02/06/2015 23:04
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
gnail
343 posts
Posted by gnail > 2015-06-12 13:27 | Report Abuse
wa, this stock so hot now, so many comment in these few days...